# info@crystallizationsummit.com

Program Schedule

Program Schedule

Thursday, September 26, 2024 (Day 1 of 2)

US EDT Keynote presentation & Activities
07:00 - 08:00 Continental breakfast
08:00 - 08:10 Greetings and Opening Speech by Dr. Yuriy Abramov, J-Star Research / Porton USA
Session 1: Crystallization of Complex Pharmaceutical Compounds
08:10 - 08:15 Introduction by Moderator, Dr. Alfred Lee, Merck & Co
08:15 - 09:05 Peptide crystallisation
Prof. Jerry Heng, Imperial College, UK
09:05 -09:55 Vepdegestrant: Development of a Scalable Crystallization Process of a PROTAC Molecule
Dr. Noalle Fellah, Pfizer, USA
09:55 -10:15 Coffee/Tea Break
10:15 – 11:05 Learnings from Solid Form Development of Complex HCV Drugs
Dr. Shuang Chen, AbbVie, USA
11:05 – 11:55 Developing and optimizing a quench-crystallization operation in drug substance manufacturing
Mr. James D. Fostinis, Amgen
11:55 – 12:00 Closing Remarks by Session Moderator
End of Session 1
12:00 – 13:00 Lunch
Session 2: Particle Engineering to Address Formulation Challenge
13:00 – 13:05 Introduction by Moderator, Dr. Jian Wang, J-Star Research/ Porton USA
13:05 – 13:55 Use of automation, dynamic image analysis, and process analytical technologies to enable data rich particle engineering efforts at the Drug Substance / Drug Product interface: A case study using Lovastatin
Dr. Jeremy M. Merritt , Eli Lilly & Co.
13:55 – 14:45 Process Development and Robust Control of Physical Attributes of an Amorphous Drug Substance
Dr. Dimitrios Zarkadas, Merck & Co, USA
14:45 – 15:05 Coffee/Tea Break
15:05 – 15:55 Addressing poor solubility and oiling-out tendencies of drug substances
Dr. Lotfi Derdour , GlaxoSmithKline, USA
15:55 – 16:45 Crystallization as a Purification Process: Visualizing Impurity Retention and its Effects on Crystal Properties
Prof. Gerard Capellades, Rowan University
16:45 - 16:50 Closing Remarks by Session Moderator
End of Session 2
16:50 – 17:00 Announcements by Chairman on Evening
18:00 – 19:00 Social Hour
End of Day 1

Friday, September 27, 2024 (Day 2 of 2)​​

US EDT Keynote presentation & Activities
07:00 -08:00 Continental breakfast
Session 3: Computational Applications for Controlled Crystallization
08:10 - 08:15 Introduction by Moderator, Dr. Yuriy Abramov, J-Star Research / Porton USA
08:15-09:05 Fast-tracking Pharmaceutical Process Optimization with Small Data and Machine Learning
Dr. Daniela Blanco, Sunthetics
09:05-09:55 Crystal structure prediction for realistic pharmaceutical targets with AIMNet2 neural network potential
Prof. Olexandr Isayev, Carnegie Mellon University
09:55 -10:15 Coffee/Tea Break
10:15 – 11:05 Computer-aided solid form design: Current challenges, future opportunities
Prof. Susan M. Reutzel-Edens, SuRE Pharma Consulting
11:05 – 11:55 Solid Form Design and Selection Utilizing Combined Experimental and Computational Techniques
Dr. Rajni Miglani Bhardwaj, Pfizer
11:55 – 12:00 Closing Remarks by Session Moderator
End of Session 3
12:00 – 13:00 Lunch
Poster Session
13:00 – 13:45 Poster Presentation
Session 4: Topical Panel Discussions
13:45 – 14:00 Introduction by Chairman
14:00 – 14:35 Challenges and Solutions of Crystallization of Complex Compounds
Moderator: TBD
14:35 – 15:10 Particle Engineering as Enabling Formulation Technique
Moderator: TBD
15:10 – 15:45 Challenges and Opportunities of Computational Support of Pharmaceutical Crystallization
Moderator: Dr. Shiva Sekharan, Schrodinger Inc, USA
15:45 – 15:55 Closing Remarks by Chairman
End of Session 4 and Day 2 (Summit)
RSS
Follow by Email
LinkedIn
Share